Daicel Life Sciences provides products and services to a wide array of the pharmaceutical market. In the area of drug delivery, we offer Daicel’s P1 SC jet-injector, approved in Japan for sub-cutaneous delivery in humans (2025). This needle-free device is designed to inject drugs intra-cellularly without the use of carriers, excipients, or vectors of any kind. In animal studies, our Actranza jet-injector has been proven to deliver mRNA and DNA into the cell (SC or IM) and achieve production of the desired protein or antibody.
Join our mailing list to receive exclusive content and offers.